Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-24T23:54:21.602Z Has data issue: false hasContentIssue false
  • English
  • Français

Inflammatory Myelopathy Presenting as a Cystic Intramedullary Spinal Cord Lesion

Published online by Cambridge University Press:  18 September 2015

B.I. Tranmer ,
T.A. Gray ,
W.J. Horsey  and
C.G. Gonsalves
B.I. Tranmer
Affiliation:
Division of Neurology, Neurosurgery and Neuroradiology. St. Michael’s Hospital and University of Toronto
T.A. Gray*
Affiliation:
Division of Neurology, Neurosurgery and Neuroradiology. St. Michael’s Hospital and University of Toronto
W.J. Horsey
Affiliation:
Division of Neurology, Neurosurgery and Neuroradiology. St. Michael’s Hospital and University of Toronto
C.G. Gonsalves
Affiliation:
Division of Neurology, Neurosurgery and Neuroradiology. St. Michael’s Hospital and University of Toronto
*
St. Michael’s Hospital, Toronto, Ontario
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A case of subacute progressive spinal tetraparesis had myelographic evidence of cervical spinal cord swelling and a delayed metrizamide computed tomographic myelogram (MCTM) suggested cavitation within the swollen spinal cord. Surgical exploration of the cervical cord revealed inflammatory changes only. No syrinx or intramedullary tumour was found. The accumulation of metrizamide within the spinal cord, as demonstrated by MCTM, did not’respresent a syrinx or a cystic tumour, but more likely an area of inflammation. Because inflammatory myelopathy may simulate an intramedullary tumor or syrinx, careful analysis of all clinical and radiological information is necessary to help make a correct diagnosis.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 11 , Issue 3 , August 1984 , pp. 399 - 401
Copyright
Copyright © Canadian Neurological Sciences Federation 1984

References

Barnett, HJM, Fox, A, Vinuela, F, Peerless, SJ (1980) Delayed metrizamide CT observations in syringomyelia. (Abstr) Ann Neurol., 8: 116.Google Scholar
Bonafe, A, Manelfe, C, Espagno, J, Guirand, B, Rascol, A (1980) Evaluation of syringomyelia with metrizamide computed tomographic myelography. J. Comput. Assist. Tomogr., 4: 792–802.Google ScholarPubMed
DiChiro, G, Schellinger, CS (1976) Computed tomography of spinal cord after lumbar intrathecal introduction of metrizamide. (Computed Assisted Myelography). Radiology, 20: 101–104.CrossRefGoogle Scholar
Drayer, B, Rosenbaum, A (1977) Metrizamide brain penetrance. Acta. Radiol. (Suppl.) 355: 280–293.Google ScholarPubMed
Dubois, P, Drayer, B, Sage, M, Osborne, D, Heinz, E (1981) Intramedullary penetrance of metrizamide in the dog spinal cord. Am. J. Neurorad., 2:313–317.Google ScholarPubMed
Feasby, T, Paty, D, Ebers, G, Fox, A (1981) Spinal cord swelling in multiple sclerosis. Can. J. Neur. Sci., 8: 151–153.CrossRefGoogle ScholarPubMed
Goldman, K (1973) Distribution and retention of 1–125 metrizamide after intravenous and suboccipital injection of rabbit, rat and cat. Acta. Radiol. 335: (Suppl.) 300–311.Google Scholar
Isherwood, I, Fawcett, RA, Forbes, W (1977) Computer tomography of the spinal canal using metrizamide. Acta. Radiol. (Stockh.), 355: (Suppl.) 229–305.Google ScholarPubMed
Winkler, S, Sackett, J (1980) Explanation of metrizamide brain penetrance: A review. J. Comput. Assist. Tomogr., 4: 191–193.CrossRefGoogle Scholar